"
Team:Imperial College London/M2
From 2009.igem.org
(Difference between revisions)
| Line 1: | Line 1: | ||
{{Imperial/09/TemplateTop}} | {{Imperial/09/TemplateTop}} | ||
| - | + | <html><p align=right><a href="https://2009.igem.org/Team:Imperial_College_London"><img style="vertical-align:bottom;" width="9%" src="http://www.clker.com/cliparts/b/4/5/9/12236111601800075995dynnamitt_home.svg.med.png"></a></html> | |
{{Imperial/09/Tabs/M2}} | {{Imperial/09/Tabs/M2}} | ||
| + | |||
| + | |||
=[[Image:II09_Thumb_m2.png|40px]]<font size='5'><b>Module 2 - Encapsulsation Overview</b></font>= | =[[Image:II09_Thumb_m2.png|40px]]<font size='5'><b>Module 2 - Encapsulsation Overview</b></font>= | ||
Revision as of 21:05, 6 October 2009
Module 2 - Encapsulsation Overview
Aside from aiding in pill manufacture, encapsulation (Module 2) allows the safe passage of polypetides through the stomach into the intestine. The encapsulation process involves the production of a physical barrier, acid resistance proteins and the preservative trehalose. Without encapsulation, our polypeptides would be denatured and degraded by stomach acid and digestive proteases respectively.
About proteolysis.
Our solution represents a fusion between probiotic treatment & polypeptide encapsulation
